Improving Health Research and Evaluation Capacity within the Government of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 158903CONT17

Opportunity Information: Apply for CDC RFA GH15 158903CONT17

This grant opportunity, titled "Improving Health Research and Evaluation Capacity within the Government of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), Center for Global Health. It sits within the health funding activity area and is tied to CFDA number 93.067, which is commonly associated with CDC global HIV/AIDS programming under PEPFAR. The overall purpose, as stated in the title and brief description, is to strengthen the Government of Tanzania's ability to carry out health research and evaluation functions that support HIV/AIDS program planning, improvement, and accountability within the PEPFAR framework.

The mechanism is a cooperative agreement rather than a standard grant, which typically means the CDC is expected to have substantial involvement in the work beyond simply providing funds. In practical terms, this usually involves ongoing technical collaboration, joint planning, and performance monitoring between the recipient and CDC staff. The opportunity is explicitly labeled as "Continuation" funding, indicating it is intended to extend or continue an existing project or partnership rather than launch a brand-new standalone effort. The listing shows an expectation of one award, reinforcing the idea that this is aimed at a specific continuing recipient or a very limited set of eligible entities rather than an open competition with multiple awards.

Eligibility is described broadly as "Others," with further clarification referenced as being in an additional eligibility text field (not included in the excerpt provided). That phrasing often signals eligibility could be limited to specific organizations, potentially including entities already partnering with the Government of Tanzania or already working under the existing cooperative agreement. The sponsor is the CDC (within HHS), and the opportunity was created on October 12, 2016, with an original closing date of December 12, 2016, placing it in a defined application window during that period.

In terms of what the program is trying to accomplish, the phrase "improving health research and evaluation capacity" suggests activities that strengthen systems and people rather than only funding service delivery. In a PEPFAR context, that capacity building commonly includes improving the ability of government counterparts to design and manage evaluations, strengthen routine monitoring and evaluation (M and E) systems, improve data quality, analyze and interpret program data, and translate findings into policy and program improvements. It can also involve building institutional capacity for operational research, supporting ethical review and research governance processes, strengthening surveillance and strategic information functions, and improving the use of evidence for decision-making across HIV prevention, care, and treatment programs. The Tanzania government focus implies a strong emphasis on embedding skills, tools, and processes within ministries, national programs, or other government bodies so that research and evaluation functions become sustainable and locally led.

The funding details in the excerpt list an award ceiling of 0, which generally indicates that the public summary did not specify a maximum funding amount, or that the ceiling is not applicable or is defined elsewhere in the full announcement. Even without a published ceiling, the "ExpectedAwards: 1" detail is important because it signals the scale of competition and the likely administrative intent: continuation support for a single implementing partner to keep advancing a defined capacity-building agenda with CDC collaboration.

Overall, this opportunity is best understood as a CDC-supported, PEPFAR-aligned continuation cooperative agreement designed to reinforce Tanzania's government-led health research and evaluation capabilities, with the goal of improving the quality and use of evidence that guides HIV/AIDS program decisions and strengthens the effectiveness, efficiency, and accountability of the national response.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Improving Health Research and Evaluation Capacity within the Government of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 12, 2016.
• Applicants must submit their applications by Dec 12, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 158903CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: